Effective chimeric antigen receptor T cells against SARS-CoV-2
Summary: Current therapies to treat coronavirus disease 2019 (COVID-19) involve vaccines against the spike protein S1 of SARS-CoV-2. Here, we outline an alternative approach involving chimeric antigen receptors (CARs) in T cells (CAR-Ts). CAR-T recognition of the SARS-CoV-2 receptor-binding domain (...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/92a1ae3a31c64365ad85696fa463ec73 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!